Read the latest news from Sobi 30 May, 2023 Sobi to relocate its global headquarters in Stockholm, Sweden 20 March, 2023 Sobi welcomes Lena Bjurner as Chief Human Resources Officer 13 March, 2023 Nordic Rare Disease Summit gathers experts to discuss how the care of patients with rare health conditions can be improved - in Stockholm, April 17, 2023 23 February, 2023 Rare Disease Day 2023: rare is our reason 14 February, 2023 Rare Strength award winners 2023 22 December, 2022 Sobi enters the Dow Jones Sustainability Indices (DJSI) 6 October, 2022 People with rare blood disorder to be supported by a new website offering symptom recognition tools and resources to improve understanding of their condition 1 July, 2022 Sobi announces launch of the INTO-HLH Registry, a disease registry for patients with Hemophagocytic Lymphohistiocytosis (HLH) 17 June, 2022 Sobi and Pfizer celebrate the opening of a new production plant in Croatia 7 April, 2022 World Haemophilia Day 2022: Sobi's position statement 28 February, 2022 3 + team win Rare Strength Awards 25 February, 2022 Celebrating Rare Disease Day around the world 24 February, 2022 Engaging with the rare patient voice 6 December, 2021 Wesström: SwedenBIO important for Sobi 5 November, 2021 FCS: the challenges of a low-fat life Pagination Current page 1 Page 2 Next page Next › Last page Last »
